Yıl: 2021 Cilt: 22 Sayı: 2 Sayfa Aralığı: 155 - 160 Metin Dili: İngilizce DOI: 10.4274/imj.galenos.2021.82698 İndeks Tarihi: 06-11-2021

Could Lycopene Protect Against Ischemia/Reperfusion Injury in the Uterus?

Öz:
Introduction: Ischemia/reperfusion damage (IRD) is one of themost important factors in the success of organ transplantation.IRD plays a role in both acute and chronic rejection. This studyaims to evaluate the effects of lycopene, which is known to bea powerful antioxidant, on experimental uterine IRD.Methods: Twenty-four albino Wistar rats were included inthe study and divided into three groups. No substances wereadministered the sham and ischemia/reperfusion groups. Theischemia/reperfusion and ischemia/reperfusion + lycopenegroups were administered ischemia for 1 h and reperfusionfor 2 h. The ischemia/reperfusion + lycopene group wasadministered 2.5 mg/kg lycopene reperfusion intraperitoneallyhalf an hour before ischemia/reperfusion. Both uterine hornswere extracted at the end of the procedure. Oxidative stress,inflammation, and apoptosis in the tissues were assessed.Results: The malondialdehyde level, nuclear factor kappa-Bimmunoreactivity, and apoptotic cell number in the lycopeneadministered group (ischemia/reperfusion + lycopene) weresignificantly decreased compared with those in the ischemia/reperfusion group (p<0.05).Conclusion: The study found that lycopene reduced the effectsof IRD on uterine tissue. Lycopene may positively affect theshort- and long-term success of organ transplantation.
Anahtar Kelime:

Likopen Uterustaki İskemi/Reperfüzyon Hasarına Karşı Koruyabilir mi?

Öz:
Amaç: İskemi/reperfüzyon hasarı (İRH) organ transplantasyonunun başarısının önündeki en önemli etkenlerden biridir. İRH hem akut hem de kronik rejeksiyonda rol oynamaktadır. Bu çalışmanın amacı güçlü bir antioksidan olduğu bilinen likopenin deneysel uterus İRH’de etkilerini değerlendirmektir. Yöntemler: Çalışmaya alınan 24 Wistar albino rat 3 gruba ayrılmıştır. Sham ve iskemi/reperfüzyon grubuna hiçbir madde verilmemiştir. İskemi/reperfüzyon ve iskemi/reperfüzyon + likopen grubuna 1 saat iskemi ve 2 saat reperfüzyon uygulanmıştır. İskemi/reperfüzyon + likopen grubuna 2,5 mg/ kg dozda likopen reperfüzyon yarım saat önce intraperitoneal olarak verilmiştir. İşlemin sonunda her iki uterin horn çıkarılmıştır. Dokularda oksidatif stres, enflamasyon ve apoptozis değerlendirilmiştir. Bulgular: Likopen uygulanan grupta (iskemi/reperfüzyon + likopen) malondialdehit seviyesi, nükleer faktör kappa-B immünoreaktivitesi ve apoptotik hücre sayısı iskemi/ reperfüzyon grubuna göre önemli ölçüde azalmıştır (p<0,05). Sonuç: Likopenin İRH’nin uterin doku üzerindeki etkilerini azalttığı saptanmıştır. Likopen, organ naklinin kısa ve uzun vadeli başarısını olumlu yönde etkileyebilir.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med 2007; 357: 1121-35.
  • 2. Brännström M, Johannesson L, Bokström H, Kvarnström N, Mölne J, DahmKähler P, et al. Livebirth after uterus transplantation. The Lancet 2015; 385: 607-16.
  • 3. Land WG. The role of postischemic reperfusion injury and other nonantigendependent inflammatory pathways in transplantation. Transplantation 2005; 79: 505-14.
  • 4. Sahin S, Ozakpinar OB, Ak K, Eroglu M, Acikel M, Tetik S, et al. The protective effects of tacrolimus on rat uteri exposed to ischemia-reperfusion injury: a biochemical and histopathologic evaluation. Fertil Steril 2014; 101: 1176-82.
  • 5. Sen R, Baltimore D. Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism. Cell 1986; 47: 921-8.
  • 6. Bradham CA, Schemmer P, Stachlewitz RF, Thurman RG, Brenner DA. Activation of nuclear factor-kappaB during orthotopic liver transplantation in rats is protective and does not require Kupffer cells. Liver Transpl Surg 1999; 5: 282-93.
  • 7. Ricciardi R, Kim RD, McDade TP, Perugini RA, Veal TM, Quarfordt SH, et al. NFkappaB expression during cold ischemia correlates with postreperfusion graft function. J Surg Res 2000; 93: 35-40.
  • 8. Turkler C, Onat T, Yildirim E, Kaplan S, Yazici GN, Mammadov R, et al. An experimental study on the use of lycopene to prevent infertility due to acute oxidative ovarian damage caused by a single high dose of methotrexate. Adv Clin Exp Med 2020; 29: 5-11.
  • 9. Kuhad A, Sharma S, Chopra K. Lycopene attenuates thermal hyperalgesia in a diabetic mouse model of neuropathic pain. Eur J Pain 2008; 12: 624-32.
  • 10. Alshatwi AA, Al Obaaid MA, Al Sedairy SA, Al-Assaf AH, Zhang JJ, Lei KY. Tomato powder is more protective than lycopene supplement against lipid peroxidation in rats. Nutr Res 2010; 30: 66-73.
  • 11. Marcondes FK, Bianchi FJ, Tanno AP. Determination of the estrous cycle phases of rats: some helpful considerations. Braz J Biol 2002; 62: 609-14.
  • 12. Wu MY, Yiang GT, Liao WT, Tsai AP, Cheng YL, Cheng PW, et al. Current Mechanistic Concepts in Ischemia and Reperfusion Injury. Cell Physiol Biochem 2018; 46: 1650-67.
  • 13. Ornellas FM, Ornellas DS, Martini SV, Castiglione RC, Ventura GM, Rocco PR, et al. Bone Marrow-Derived Mononuclear Cell Therapy Accelerates Renal Ischemia-Reperfusion Injury Recovery by Modulating Inflammatory, Antioxidant and Apoptotic Related Molecules. Cell Physiol Biochem 2017; 41: 1736-52.
  • 14. Díaz‐García C, Akhi SN, Martínez‐Varea A, Brännström M. The effect of warm ischemia at uterus transplantation in a rat model. Acta Obstet Gynecol Scand 2013; 92: 152-9.
  • 15. Kisu I, Umene K, Adachi M, Emoto K, Nogami Y, Banno K, et al. Allowable warm ischemic time and morphological and biochemical changes in uterine ischemia/reperfusion injury in cynomolgus macaque: a basic study for uterus transplantation. Hum Reprod 2017; 32: 2026-35.
  • 16. Bayramoglu G, Bayramoglu A, Altuner Y, Uyanoglu M, Colak S. The effects of lycopene on hepatic ischemia/reperfusion injury in rats. Cytotechnology 2015; 67: 487-91.
  • 17. Jonker D, Kuper CF, Fraile N, Estrella A, Rodríguez Otero C. Ninety-day oral toxicity study of lycopene from Blakeslea trispora in rats. Regul Toxicol Pharmacol 2003; 37: 396-406.
  • 18. Lei X, Lei L, Zhang Z, Cheng Y. Neuroprotective effects of lycopene pretreatment on transient global cerebral ischemia-reperfusion in rats: The role of the Nrf2/ HO‑1 signaling pathway. Mol Med Rep 2016; 13: 412-8.
  • 19. Kulhan NG, Kulhan M, Turkler C, Ata N, Kiremitli T, Kiremitli S, et al. Effect of lycopene on oxidative ovary-damage induced by cisplatin in rats. Gen Physiol Biophys 2019; 38: 253-8.
  • 20. Anoopkumar‐Dukie S, Walker RB, Daya S. A sensitive and reliable method for the detection of lipid peroxidation in biological tissues. J Pharm Pharmacol 2001; 53: 263-6.
  • 21. Lee MC, Velayutham M, Komatsu T, Hille R, Zweier JL. Measurement and characterization of superoxide generation from xanthine dehydrogenase: a redox-regulated pathway of radical generation in ischemic tissues. Biochemistry 2014; 53: 6615-23.
  • 22. Staal F, Roederer M, Herzenberg LA. Intracellular thiols regulate activation of nuclear factor kappa B and transcription of human immunodeficiency virus. Proc Natl Acad Sci U S A 1990; 87: 9943-7.
  • 23. Schreck R, Rieber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J 1991; 10: 2247-58.
  • 24. Oliveira-Marques V, Marinho HS, Cyrne L, Antunes F. Role of hydrogen peroxide in NF-kappaB activation: from inducer to modulator. Antioxid Redox Signal 2009; 11: 2223-43.
  • 25. Vranková S, Barta A, Klimentová J, Dovinová I, Líšková S, Dobešová Z, et al. The Regulatory Role of Nuclear Factor Kappa B in the Heart of Hereditary Hypertriglyceridemic Rat. Oxid Med Cell Longev 2016; 2016: 9814038.
  • 26. Çakır M, Tekin S, Doğanyiğit Z, Çakan P, Kaymak E. The protective effect of cannabinoid type 2 receptor activation on renal ischemia-reperfusion injury. Mol Cell Biochem 2019: 462: 123-32.
  • 27. Zhang Y, Zhao J, Li R, Lau WB, Yuan YX, Liang B, et al. AdipoRon, the first orally active adiponectin receptor activator, attenuates postischemic myocardial apoptosis through both AMPK-mediated and AMPK-independent signalings. Am J Physiol Endocrinol Metab 2015; 309: E275-82.
  • 28. Anversa P, Cheng W, Liu Y, Leri A, Redaelli G, Kajstura J. Apoptosis and myocardial infarction. Basic Res Cardiol 1998; 93: s008-s12.
  • 29. Liu D. Effects of procyanidin on cardiomyocyte apoptosis after myocardial ischemia reperfusion in rats. BMC Cardiovasc Disord 2018; 18: 35.
APA Onat T, Doğanyiğit Z, Demir çaltekin M, Turkler C, KAYMAK E, Altındağ M (2021). Could Lycopene Protect Against Ischemia/Reperfusion Injury in the Uterus?. , 155 - 160. 10.4274/imj.galenos.2021.82698
Chicago Onat Taylan,Doğanyiğit Züleyha,Demir çaltekin Melike,Turkler Can,KAYMAK EMIN,Altındağ Mehmet Murat Could Lycopene Protect Against Ischemia/Reperfusion Injury in the Uterus?. (2021): 155 - 160. 10.4274/imj.galenos.2021.82698
MLA Onat Taylan,Doğanyiğit Züleyha,Demir çaltekin Melike,Turkler Can,KAYMAK EMIN,Altındağ Mehmet Murat Could Lycopene Protect Against Ischemia/Reperfusion Injury in the Uterus?. , 2021, ss.155 - 160. 10.4274/imj.galenos.2021.82698
AMA Onat T,Doğanyiğit Z,Demir çaltekin M,Turkler C,KAYMAK E,Altındağ M Could Lycopene Protect Against Ischemia/Reperfusion Injury in the Uterus?. . 2021; 155 - 160. 10.4274/imj.galenos.2021.82698
Vancouver Onat T,Doğanyiğit Z,Demir çaltekin M,Turkler C,KAYMAK E,Altındağ M Could Lycopene Protect Against Ischemia/Reperfusion Injury in the Uterus?. . 2021; 155 - 160. 10.4274/imj.galenos.2021.82698
IEEE Onat T,Doğanyiğit Z,Demir çaltekin M,Turkler C,KAYMAK E,Altındağ M "Could Lycopene Protect Against Ischemia/Reperfusion Injury in the Uterus?." , ss.155 - 160, 2021. 10.4274/imj.galenos.2021.82698
ISNAD Onat, Taylan vd. "Could Lycopene Protect Against Ischemia/Reperfusion Injury in the Uterus?". (2021), 155-160. https://doi.org/10.4274/imj.galenos.2021.82698
APA Onat T, Doğanyiğit Z, Demir çaltekin M, Turkler C, KAYMAK E, Altındağ M (2021). Could Lycopene Protect Against Ischemia/Reperfusion Injury in the Uterus?. İstanbul Medical Journal, 22(2), 155 - 160. 10.4274/imj.galenos.2021.82698
Chicago Onat Taylan,Doğanyiğit Züleyha,Demir çaltekin Melike,Turkler Can,KAYMAK EMIN,Altındağ Mehmet Murat Could Lycopene Protect Against Ischemia/Reperfusion Injury in the Uterus?. İstanbul Medical Journal 22, no.2 (2021): 155 - 160. 10.4274/imj.galenos.2021.82698
MLA Onat Taylan,Doğanyiğit Züleyha,Demir çaltekin Melike,Turkler Can,KAYMAK EMIN,Altındağ Mehmet Murat Could Lycopene Protect Against Ischemia/Reperfusion Injury in the Uterus?. İstanbul Medical Journal, vol.22, no.2, 2021, ss.155 - 160. 10.4274/imj.galenos.2021.82698
AMA Onat T,Doğanyiğit Z,Demir çaltekin M,Turkler C,KAYMAK E,Altındağ M Could Lycopene Protect Against Ischemia/Reperfusion Injury in the Uterus?. İstanbul Medical Journal. 2021; 22(2): 155 - 160. 10.4274/imj.galenos.2021.82698
Vancouver Onat T,Doğanyiğit Z,Demir çaltekin M,Turkler C,KAYMAK E,Altındağ M Could Lycopene Protect Against Ischemia/Reperfusion Injury in the Uterus?. İstanbul Medical Journal. 2021; 22(2): 155 - 160. 10.4274/imj.galenos.2021.82698
IEEE Onat T,Doğanyiğit Z,Demir çaltekin M,Turkler C,KAYMAK E,Altındağ M "Could Lycopene Protect Against Ischemia/Reperfusion Injury in the Uterus?." İstanbul Medical Journal, 22, ss.155 - 160, 2021. 10.4274/imj.galenos.2021.82698
ISNAD Onat, Taylan vd. "Could Lycopene Protect Against Ischemia/Reperfusion Injury in the Uterus?". İstanbul Medical Journal 22/2 (2021), 155-160. https://doi.org/10.4274/imj.galenos.2021.82698